Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry

by Ali M. Saeed, MD, PhD, Rahul Khairnar, PhD, Ankur M. Sharma, MD, Gary L. Larson, MD, Henry K. Tsai, MD, Chiachien J. Wang, MD, PhD, Lia M. Halasz, MD, Prakash Chinnaiyan, MD, Carlos E. Vargas, MD, Mark V. Mishra, MD
Published 2020-09-01

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostat...

by Carlos E. Vargas, MD, Matthew Q. Schmidt, MD, Joshua R. Niska, MD, William F. Hartsell, MD, Sameer R. Keole, MD, Lucius Doh, MD, John Han-Chih Chang, MD, Christopher Sinesi, MD, Rossio Rodriquez, CTR, Mark Pankuch, PhD, Gary L. Larson, MD
Published 2018-07-01

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors

by Nathan Y. Yu, MD, Mauricio E. Gamez, MD, William F. Hartsell, MD, Henry K. Tsai, MD, George E. Laramore, MD, PhD, Gary L. Larson, MD, Charles B. Simone, II, MD, Carl Rossi, MD, Sanford R. Katz, MD, Matthew R. Buras, MS, Michael A. Golafshar, MS, Carlos E. Vargas, MD, Samir H. Patel, MD
Published 2019-10-01